title: Neuroleptic malignant syndrome: a review for neurohospitalists.
abstract: Neuroleptic malignant syndrome (NMS) is a life-threatening idiosyncratic reaction to antipsychotic drugs characterized by fever, altered mental status, muscle rigidity, and autonomic dysfunction. It has been associated with virtually all neuroleptics, including newer atypical antipsychotics, as well as a variety of other medications that affect central dopaminergic neurotransmission. Although uncommon, NMS remains a critical consideration in the differential diagnosis of patients presenting with fever and mental status changes because it requires prompt recognition to prevent significant morbidity and death. Treatment includes immediately stopping the offending agent and implementing supportive measures, as well as pharmacological interventions in more severe cases. Maintaining vigilant awareness of the clinical features of NMS to diagnose and treat the disorder early, however, remains the most important strategy by which physicians can keep mortality rates low and improve patient outcomes.
authors: Department of Neurology, University of Colorado Denver School of Medicine, Aurora, CO, USA.
authors: Brian D
authors: BD
authors: Berman
keywords: movement disorders; neurohospitalist; neuroleptic malignant syndrome
references: Neurosciences (Riyadh). 2006 Apr;11(2):104-6
references: 22266559
references: Ann Emerg Med. 1996 Nov;28(5):520-6
references: 8909274
references: Med Clin North Am. 1993 Jan;77(1):185-202
references: 8093494
references: J Psychiatr Res. 1995 May-Jun;29(3):233-44
references: 7473299
references: J Clin Psychiatry. 2006 Apr;67(4):677
references: 16669738
references: Acta Psychiatr Scand. 1990 Jan;81(1):3-5
references: 2184638
references: Parkinsonism Relat Disord. 2002 Dec;9(2):115-6
references: 12473402
references: Eur Neurol. 1997;38 Suppl 2:56-9
references: 9387804
references: Clin Neuropharmacol. 2002 Jul-Aug;25(4):183-93
references: 12151905
references: Intensive Care Med. 1990;16(4):267-8
references: 2358561
references: Am J Psychiatry. 1985 Oct;142(10):1137-45
references: 2863986
references: Mov Disord. 1996 Nov;11(6):726-8
references: 8914102
references: Eur Psychiatry. 1996;11(4):212-3
references: 19698454
references: Am J Psychiatry. 1986 Oct;143(10):1227-33
references: 2876647
references: Biol Psychiatry. 1998 Feb 15;43(4):303-5
references: 9513741
references: Emerg Med Clin North Am. 2007 May;25(2):477-97; abstract x
references: 17482029
references: Neurology. 1981 Feb;31(2):132-7
references: 6110195
references: Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S54-64
references: 15052515
references: Psychopharmacol Bull. 1988;24(1):25-9
references: 3290944
references: Psychopharmacol Bull. 1991;27(3):381-4
references: 1685592
references: Mov Disord. 1997 Mar;12(2):246-8
references: 9087987
references: J Nerv Ment Dis. 1988 Apr;176(4):234-41
references: 2895164
references: CMAJ. 1991 Oct 1;145(7):817-9
references: 1913410
references: Clin Auton Res. 2000 Aug;10(4):193-6
references: 11029016
references: Ann Pharmacother. 1999 May;33(5):644-5
references: 10369632
references: Biol Psychiatry. 1998 Oct 15;44(8):748-54
references: 9798079
references: Psychosomatics. 1989 Fall;30(4):454-6
references: 2572030
references: J Nerv Ment Dis. 1986 Aug;174(8):493-5
references: 3090198
references: CMAJ. 2003 May 27;168(11):1439-42
references: 12771076
references: DICP. 1989 Sep;23(9):713
references: 2800590
references: Br J Psychiatry. 1991 Jun;158:850-3
references: 1678666
references: Am J Psychiatry. 1986 Dec;143(12):1587-90
references: 3789214
references: Clin Neuropharmacol. 1994 Jun;17(3):243-59
references: 9316670
references: Br J Anaesth. 2000 Jul;85(1):129-35
references: 10928001
references: J Clin Psychiatry. 1982 Sep;43(9):381-2
references: 7118846
references: World J Biol Psychiatry. 2007;8(1):42-4
references: 17366349
references: Aust N Z J Psychiatry. 1999 Oct;33(5):650-9
references: 10544988
references: Arch Gen Psychiatry. 1989 Oct;46(10):914-8
references: 2572206
references: Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):57-60
references: 12555236
references: Am J Psychiatry. 1989 Jun;146(6):717-25
references: 2567121
references: Neurotoxicology. 2008 Jul;29(4):750-1
references: 18539333
references: J Clin Psychiatry. 1998 May;59(5):254-5
references: 9632037
references: J Psychopharmacol. 2001 Mar;15(1):61-3
references: 11277611
references: Int J Neurosci. 2009;119(12):2274-9
references: 19916856
references: Lancet. 1991 Jul 20;338(8760):149-51
references: 1677067
references: Expert Opin Drug Saf. 2008 Nov;7(6):761-9
references: 18983222
references: Arch Intern Med. 1991 Apr;151(4):794-6
references: 1672810
references: Fortschr Neurol Psychiatr. 2009 Apr;77(4):203-11
references: 19347791
references: Arch Intern Med. 1989 Sep;149(9):1927-31
references: 2673115
references: Semin Neurol. 1991 Sep;11(3):228-35
references: 1947485
references: CNS Spectr. 2000 Jul;5(7):54-7
references: 18197156
references: J Clin Exp Psychopathol. 1956 Apr-Jun;17(2):189-92
references: 13345882
references: J Clin Psychiatry. 1989 Jan;50(1):18-25
references: 2562951
references: J Clin Psychiatry. 1991 May;52(5):208-12
references: 1674508
references: J Clin Psychopharmacol. 2009 Oct;29(5):497-9
references: 19745653
references: Am J Psychiatry. 2007 Jun;164(6):870-6
references: 17541044
references: Psychiatr Serv. 1998 Sep;49(9):1163-72
references: 9735957
references: J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):271-3
references: 7897404
references: Am J Psychiatry. 1999 Feb;156(2):169-80
references: 9989551
references: Neurol Clin. 2004 May;22(2):389-411
references: 15062519
references: Eur J Pediatr. 2001 Jun;160(6):401
references: 11421428
references: Pharmacotherapy. 2003 Jun;23(6):811-5
references: 12820823
references: Ann Med Psychol (Paris). 1960 Jan;118(1):145-52
references: 13815606
references: Hosp Med. 1999 Jun;60(6):448-9
references: 10492720
references: Am J Med. 2000 Apr 15;108(6):517-8
references: 10866587
references: J ECT. 1999 Jun;15(2):158-63
references: 10378156
references: Acad Radiol. 2002 Jul;9(7):826-9
references: 12139101